A satellite symposium broadcast at ASHP Midyear 2025.
Program Description
Achieving optimal diabetes management and individualized glycemic goals often requires insulin therapy. Insulin is recommended by clinical guidelines to prevent microvascular and macrovascular complications in people living with type 2 diabetes (T2D) when glycemic levels remain above the recommended target. However, the significant personal and logistical burden of insulin regimens, which demand multiple daily injections, can severely impact a patient's daily life and overall well-being. This challenge frequently contributes to therapeutic and clinical inertia, where necessary treatment adjustments are delayed due to concerns over regimen complexity or patient difficulties. This session is specifically designed for practicing pharmacists to address these challenges by comprehensively reviewing the evolving landscape of insulin care, differentiating the efficacy and safety profiles of existing formulations, and examining the potential impact of emerging insulin formulations as well as other strategies to simplify care and alleviate the burden. Presented in a unique, highly interactive workshop format, this session includes an expert faculty panel that will present a collaborative patient case and focused discussions. Pharmacists will gain the necessary skills to identify patients experiencing adherence challenges to complex regimens, apply best practices in sensitive titration and counseling, and highlight shared decision-making strategies to overcome inertia and step into a stronger, more patient-centric leadership role in diabetes care.
Target audience: Community pharmacist, health-system pharmacist, ambulatory care pharmacist
Type of activity: Application
Release date: December 10, 2025
Expiration date: February 10, 2026
Time to complete activity: 1.5 hours
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Apply strategies to identify patients with type 2 diabetes (T2D) receiving insulin therapy who are at high risk for nonadherence by evaluating individualized glycemic targets and patient-specific factors
- Use glycemic data to propose guideline-aligned insulin modification plans and facilitate therapy adjustment for a person living with T2D receiving insulin therapy
- Employ motivational interviewing and communication techniques to uncover specific patient-related barriers to insulin adherence supported by individualized patient action plans